Monitoring T Cells Responses Mounted by Therapeutic Cancer Vaccines

With the regulatory approval of Provenge and Talimogene laherparepvec (T-VEC) for the treatment of metastatic prostate cancer and advanced melanoma respectively, and other promising clinical trials outcomes, cancer vaccine is gaining prominence as a cancer therapeutic agent. Cancer vaccine works to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Kue Peng, Zainal, Nur Syafinaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082312/
https://www.ncbi.nlm.nih.gov/pubmed/33937323
http://dx.doi.org/10.3389/fmolb.2021.623475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082312/
https://www.ncbi.nlm.nih.gov/pubmed/33937323
http://dx.doi.org/10.3389/fmolb.2021.623475

Ejemplares similares